Dermata Therapeutics, Inc. (DRMA) Misses Q1 EPS by 27c

Dermata Therapeutics, Inc. (NASDAQ: DRMA) reported Q1 EPS of ($0.47), $0.27 worse than the analyst estimate of ($0.20).

For earnings history and earnings-related data on Dermata Therapeutics, Inc. (DRMA) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Lockheed Martin frontrunner for $3.5B Ultra Maritime deal, sources say - FT
• Danone SA (BN:FP) (DANOY) PT Raised to EUR63 at Deutsche Bank